Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPulmonary Disease Physician in Boston, MA
NPI: 1396721841Primary Practice Location
TUFTS MEDICAL CENTER
755 Washington St, Boston, MA
Primary Employer
Pratt Medical Group, Inc - Pulmonary Disease
tuftsmedicine.org
HQ Phone
Get M.D. Harrison's Phone Numberphone_androidMobile
Get M.D. Harrison's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 109 | 233 |
| 2 | 93451Insertion of catheter for diagnostic evaluation of right heart structures | 73 | 77 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 62 | 62 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 52 | 105 |
| 5 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 39 | 109 |
Authors: Robert Simms, Deepa Gopal, Noyan Gokce
Journal: Arthritis Care Res (Hoboken)
Authors: Murali Chakinala, Kristin Highland, Anna Hemnes, Kelly Chin, Vallerie Mclaughlin
Journal: J Heart Lung Transplant
Publication Date: 2025-05-14
Lead Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Intervention / Treatment: OTHER: Placebo, DRUG: Sotatercept
Lead Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: Sotatercept, DRUG: Background PAH Therapy
Lead Sponsor: Civi Biopharma, Inc.
Intervention / Treatment: DRUG: Iloprost Injection, for intravenous use, DRUG: Placebo IV infusion
